The company said it will use the funds to further validate its vertebral body augmentation system, VCFix, through testing and clinical studies. The system earned a breakthrough device designation from the FDA in September.
VCFix is a 3D-printed vertebral fracture implant that stimulates bone ingrowth and stability without bone cement.
